BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

504 related articles for article (PubMed ID: 29048427)

  • 21. Inhibition of HDAC6 protects against rhabdomyolysis-induced acute kidney injury.
    Shi Y; Xu L; Tang J; Fang L; Ma S; Ma X; Nie J; Pi X; Qiu A; Zhuang S; Liu N
    Am J Physiol Renal Physiol; 2017 Mar; 312(3):F502-F515. PubMed ID: 28052874
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tubastatin, a selective histone deacetylase 6 inhibitor shows anti-inflammatory and anti-rheumatic effects.
    Vishwakarma S; Iyer LR; Muley M; Singh PK; Shastry A; Saxena A; Kulathingal J; Vijaykanth G; Raghul J; Rajesh N; Rathinasamy S; Kachhadia V; Kilambi N; Rajgopal S; Balasubramanian G; Narayanan S
    Int Immunopharmacol; 2013 May; 16(1):72-8. PubMed ID: 23541634
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of HDAC6 by Tubastatin A reduces chondrocyte oxidative stress in chondrocytes and ameliorates mouse osteoarthritis by activating autophagy.
    Shen Z; Ji K; Cai Z; Huang C; He X; Xu H; Chen G
    Aging (Albany NY); 2021 Mar; 13(7):9820-9837. PubMed ID: 33744850
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tubastatin A, an HDAC6 inhibitor, alleviates stroke-induced brain infarction and functional deficits: potential roles of α-tubulin acetylation and FGF-21 up-regulation.
    Wang Z; Leng Y; Wang J; Liao HM; Bergman J; Leeds P; Kozikowski A; Chuang DM
    Sci Rep; 2016 Jan; 6():19626. PubMed ID: 26790818
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Histone deacetylase 6 inhibition restores autophagic flux to promote functional recovery after spinal cord injury.
    Zheng Z; Zhou Y; Ye L; Lu Q; Zhang K; Zhang J; Xie L; Wu Y; Xu K; Zhang H; Xiao J
    Exp Neurol; 2020 Feb; 324():113138. PubMed ID: 31794745
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Critical role of the HDAC6-cortactin axis in human megakaryocyte maturation leading to a proplatelet-formation defect.
    Messaoudi K; Ali A; Ishaq R; Palazzo A; Sliwa D; Bluteau O; Souquère S; Muller D; Diop KM; Rameau P; Lapierre V; Marolleau JP; Matthias P; Godin I; Pierron G; Thomas SG; Watson SP; Droin N; Vainchenker W; Plo I; Raslova H; Debili N
    Nat Commun; 2017 Nov; 8(1):1786. PubMed ID: 29176689
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacological Amelioration of Cone Survival and Vision in a Mouse Model for Leber Congenital Amaurosis.
    Li S; Samardzija M; Yang Z; Grimm C; Jin M
    J Neurosci; 2016 May; 36(21):5808-19. PubMed ID: 27225770
    [TBL] [Abstract][Full Text] [Related]  

  • 28. How to Distinguish Between the Activity of HDAC1-3 and HDAC6 with Western Blot.
    Beyer M; Kiweler N; Mahboobi S; Krämer OH
    Methods Mol Biol; 2017; 1510():355-364. PubMed ID: 27761834
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacological blockade of HDAC6 attenuates cancer progression by inhibiting IL-1β and modulating immunosuppressive response in OSCC.
    Mahale A; Routholla G; Lavanya S; Sharma P; Ghosh B; Kulkarni OP
    Int Immunopharmacol; 2024 May; 132():111921. PubMed ID: 38547770
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tubastatin A suppresses renal fibrosis via regulation of epigenetic histone modification and Smad3-dependent fibrotic genes.
    Choi SY; Ryu Y; Kee HJ; Cho SN; Kim GR; Cho JY; Kim HS; Kim IK; Jeong MH
    Vascul Pharmacol; 2015 Sep; 72():130-40. PubMed ID: 25921924
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of histone deacetylase 6 restores intestinal tight junction in hemorrhagic shock.
    Chang Z; Li Y; He W; Liu B; Duan X; Halaweish I; Bambakidis T; Pan B; Liang Y; Nikolian VC; Georgoff P; Alam HB
    J Trauma Acute Care Surg; 2016 Sep; 81(3):512-9. PubMed ID: 27257709
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of histone deacetylase 6 acetylates and disrupts the chaperone function of heat shock protein 90: a novel basis for antileukemia activity of histone deacetylase inhibitors.
    Bali P; Pranpat M; Bradner J; Balasis M; Fiskus W; Guo F; Rocha K; Kumaraswamy S; Boyapalle S; Atadja P; Seto E; Bhalla K
    J Biol Chem; 2005 Jul; 280(29):26729-34. PubMed ID: 15937340
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of cell migration and induction of apoptosis by a novel class II histone deacetylase inhibitor, MCC2344.
    Dawood M; Fleischer E; Klinger A; Bringmann G; Shan L; Efferth T
    Pharmacol Res; 2020 Oct; 160():105076. PubMed ID: 32659428
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increased acetylation of Peroxiredoxin1 by HDAC6 inhibition leads to recovery of Aβ-induced impaired axonal transport.
    Choi H; Kim HJ; Kim J; Kim S; Yang J; Lee W; Park Y; Hyeon SJ; Lee DS; Ryu H; Chung J; Mook-Jung I
    Mol Neurodegener; 2017 Feb; 12(1):23. PubMed ID: 28241840
    [TBL] [Abstract][Full Text] [Related]  

  • 35. hnRNPK modulates selective quality-control autophagy by downregulating the expression of HDAC6 in 293 cells.
    Li Z; Liu X; Ma J; Zhang T; Gao X; Liu L
    Int J Oncol; 2018 Nov; 53(5):2200-2212. PubMed ID: 30106132
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tubastatin ameliorates pulmonary fibrosis by targeting the TGFβ-PI3K-Akt pathway.
    Saito S; Zhuang Y; Shan B; Danchuk S; Luo F; Korfei M; Guenther A; Lasky JA
    PLoS One; 2017; 12(10):e0186615. PubMed ID: 29045477
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Structural insights into HDAC6 tubulin deacetylation and its selective inhibition.
    Miyake Y; Keusch JJ; Wang L; Saito M; Hess D; Wang X; Melancon BJ; Helquist P; Gut H; Matthias P
    Nat Chem Biol; 2016 Sep; 12(9):748-54. PubMed ID: 27454931
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tubastatin A/ACY-1215 improves cognition in Alzheimer's disease transgenic mice.
    Zhang L; Liu C; Wu J; Tao JJ; Sui XL; Yao ZG; Xu YF; Huang L; Zhu H; Sheng SL; Qin C
    J Alzheimers Dis; 2014; 41(4):1193-205. PubMed ID: 24844691
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tektin4 loss promotes triple-negative breast cancer metastasis through HDAC6-mediated tubulin deacetylation and increases sensitivity to HDAC6 inhibitor.
    Ge LP; Jin X; Yang YS; Liu XY; Shao ZM; Di GH; Jiang YZ
    Oncogene; 2021 Mar; 40(12):2323-2334. PubMed ID: 33654196
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Overexpressed HDAC8 in cervical cancer cells shows functional redundancy of tubulin deacetylation with HDAC6.
    Vanaja GR; Ramulu HG; Kalle AM
    Cell Commun Signal; 2018 May; 16(1):20. PubMed ID: 29716651
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.